Jan 21, 2021

Tissue Regenix announces appointment of David Cocke as its chief financial officer with immediate effect Cocke has over 29 years of experience in the medical device industry holding senior finance and operations positions and In 1997, he founded NuPak Medical, an ISO-certified contract manufacturer of sterile disposable medical device NuPak Medical was acquired by Katena Products, Inc. in 2017 and Cocke remained with the business post-acquisition until early 2021 Tissue Regenix PLC ( LON:TRX ), the regenerative medical devices company, announced that it has appointed David Cocke as its chief financial officer (CFO) and director to the board with immediate effect. The company noted that Cocke has over 29 years of experience in the medical device industry holding senior finance and operations positions. In 1997, he founded NuPak Medical, an ISO-certified contract manufacturer of sterile disposable medical devices, with the company turning cash flow positive in two years and growing the production volume from 50,000 to 3mln over time. NuPak Medical was acquired by Katena Products, Inc. in 2017 and Cocke remained with the business post-acquisition until early 2021, leading the expansion to double the cleanroom capacity and assembly space on-time and on-budget.